- Home
- LAB vs IGD Comparison
LAB vs IGD Comparison
Compare LAB & IGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- IGD
- Stock Information
- Founded
- LAB 1999
- IGD N/A
- Country
- LAB United States
- IGD United States
- Employees
- LAB N/A
- IGD N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- IGD Trusts Except Educational Religious and Charitable
- Sector
- LAB Industrials
- IGD Finance
- Exchange
- LAB Nasdaq
- IGD Nasdaq
- Market Cap
- LAB 473.2M
- IGD 472.4M
- IPO Year
- LAB 2011
- IGD N/A
- Fundamental
- Price
- LAB $1.35
- IGD $5.95
- Analyst Decision
- LAB Buy
- IGD
- Analyst Count
- LAB 2
- IGD 0
- Target Price
- LAB $2.50
- IGD N/A
- AVG Volume (30 Days)
- LAB 1.1M
- IGD 215.3K
- Earning Date
- LAB 10-29-2025
- IGD 01-01-0001
- Dividend Yield
- LAB N/A
- IGD 9.15%
- EPS Growth
- LAB N/A
- IGD N/A
- EPS
- LAB N/A
- IGD N/A
- Revenue
- LAB $172,271,000.00
- IGD N/A
- Revenue This Year
- LAB N/A
- IGD N/A
- Revenue Next Year
- LAB N/A
- IGD N/A
- P/E Ratio
- LAB N/A
- IGD N/A
- Revenue Growth
- LAB 76.33
- IGD N/A
- 52 Week Low
- LAB $0.92
- IGD $4.60
- 52 Week High
- LAB $2.32
- IGD $5.26
- Technical
- Relative Strength Index (RSI)
- LAB 55.30
- IGD 57.35
- Support Level
- LAB $1.27
- IGD $5.86
- Resistance Level
- LAB $1.41
- IGD $6.02
- Average True Range (ATR)
- LAB 0.08
- IGD 0.05
- MACD
- LAB 0.01
- IGD 0.00
- Stochastic Oscillator
- LAB 68.18
- IGD 56.38
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About IGD Voya Global Equity Dividend and Premium Opportunity Fund
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.